Curasight announced a rights issue targeting DKK 100m, backed by two new shareholders, partner Curium and Pentwater. Together with management and BoD, they have committed to an aggregate c. DKK 27.7m, or c. 27.7% of the rights issue, and with existing shareholders' commitments a total DKK 47m of the rights issue is covered. Short term, rights issues typically pressure shares, but we view it as a positive development for Curasight's long-term ability to execute.
LÄS MER